New pill shows promise for diabetes control in Real-World study
NCT ID NCT04601740
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study followed 145 adults with type 2 diabetes who took once-daily oral semaglutide (Rybelsus) as part of their normal care. Researchers measured changes in blood sugar (HbA1c) and body weight over 8-10 months. The goal was to see how well the medication works in everyday life, not just in strict research settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- oral semaglutide (Rybelsus)
- What this could lead to
- If successful, this study could confirm that oral semaglutide helps control blood sugar and reduce weight in real-world type 2 diabetes patients.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less reliable. It is also small (145 people) and only in the Netherlands, so findings may not apply broadly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Master Centre Netherlands
Alphen aan den Rijn, 2408 AV, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a heart drug tame blood sugar and weight in diabetes?
- Can a puff of insulin replace a needle for diabetes?
- Could a quick insulin shot stop Steroid-Induced blood sugar spikes?
- Can a puff of insulin replace a daily shot for diabetes?
- Could a Dairy-Rich diet tame type 2 diabetes?
- Can a traditional herbal remedy tame type 2 diabetes?